Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

White House Medicare Rx Plans Include $77 Bil. Medicaid Expansion

Executive Summary

The White House is proposing expanded drug coverage for seniors through state Medicaid programs as part of a package of interim approaches toward a comprehensive Medicare prescription drug benefit

You may also be interested in...



White House Offers $400 Bil. For Medicare; Less Room On President’s Agenda

The White House's proposed $400 bil. funding for Medicare reform and prescription drug coverage is at the top end of the level GOP legislators were comfortable with during the Rx debate in 2002

White House Offers $400 Bil. For Medicare; Less Room On President’s Agenda

The White House's proposed $400 bil. funding for Medicare reform and prescription drug coverage is at the top end of the level GOP legislators were comfortable with during the Rx debate in 2002

GOP Victories Spell Relief On Rx Pricing; Will State Budgets Cause Heartburn?

Burgeoning state healthcare costs are likely to take center stage on Capitol Hill during debates over drug pricing and Medicare pharmacy benefit legislation in the new year

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS039267

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel